Abundance of immunologically active alanine aminotransferase in sera of liver cirrhosis and hepatocellular carcinoma patients

Clinical Chemistry

Volumn 55, Issue 5, 2009, Pages 1022-1025

  Hyun, Jeong Kim ^a   Sang, Wook Oh ^b   Dong, Joon Kim ^c   Eui, Yul Choi ^a  

^a Hallym University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Hallym University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; MONOCLONAL ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; RELIABILITY;

ALANINE TRANSAMINASE; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS; LIVER NEOPLASMS; ROC CURVE;

EID: 65949103415     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.102996     Document Type: Article

References (15)

1. Felig P. The glucose-alanine cycle. Metabolism 1973;22:179-207.
2. Daxboeck F, Gattringer R, Mustafa S, Bauer C, Assadian O. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect 2005;11:507-510 (Pubitemid 40744402)
3. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 2000;46:2027-2049
4. Sherman KE. Alanine aminotransferase in clinical practice. Arch Intern Med 1991;151:260-265
5. Rej R. Aminotransferase in disease. Clin Lab Med 1989;9:667-687 (Pubitemid 20021132)
6. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577 (Pubitemid 23118304)
7. Xuan GS, Oh SW, Choi EY. Development of an electrochemical immunosensor for alanine aminotransferase. Biosens Bioelectron 2003;19:365-371 (Pubitemid 37410220)
8. Okada M, Murakami Y, Miyamoto E. Glycation and inactivation of aspartate aminotransferase in diabetic rat tissues. J Nutr Sci Vitaminol (Tokyo) 1997;43:463-469 (Pubitemid 27380333)
9. Beránek M, Drsata J, Palicka V. Inhibitory effect of glycation on catalytic activity of alanine aminotransferase. Mol Cell Biochem 2001;218:35-39 (Pubitemid 32294133)
10. Maekawa M, Abe H, Hara K. A novel explanation for low alanine aminotransferase activity in human serum by IgG inhibitor. Clin Chem Lab Med 2002;40:848-849
11. Maekawa M, Sudo K, Iwahara K, Kanno T. Lactate dehydrogenase inhibition by immunoglobulin G in human serum. Clin Chem 1986;32:1347-1349 (Pubitemid 17020835)
12. Kalambokis G, Christou L, Stefanou D, Arkoumani E, Tsianos EV. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol 2007;13:5783-5786 (Pubitemid 350120238)
13. Tameda M, Shiraki K, Ooi K, Takase K, Kosaka Y, Nobori T, et al. Aspartate aminotransferase-immunoglobulin complexes in patients with chronic liver disease. World J Gastroenterol 2005;11:1529-1531
14. Mastroianni A, Longoni PD, Franzini C, Facchetti G. Importance of pyridoxal-5′-phosphate addition to the assay medium for the measurement of catalytic concentrations of plasma aspartate and alanine aminotransferases in patients undergoing antineoplastic chemotherapy. Eur J Clin Chem Clin Biochem 1996;34:507-510 (Pubitemid 126813862)
15. Rej R. Immunochemical quantitation of isoenzymes of aspartate aminotransferase and lactate dehydrogenase. Clin Biochem 1983;16:17-19